1. Recombinant human erythropoietin (rhEPO) in the prevention and treatment of chemotherapy-induced anaemia

   • MR Nowrousian

   Editorial 01 September 1998 Pages: 141 - 144

2. Role of hepatocyte growth factor and its receptorc-met in multiple myeloma

   • Carina Seidel
   • Magne Børset
   • Anders Waage

   Review 01 September 1998 Pages: 145 - 153

3. Homing behaviour of the malignant cell clone in multiple myeloma

   • Ivan Van Riet
   • Karin Vanderkerken
   • Ben Van Camp

   Review 01 September 1998 Pages: 154 - 164

4. Initial transforming event in myelodysplastic syndromes may be viral: case for cytomegalovirus

   • Azra Raza

   Hypothesis 01 September 1998 Pages: 165 - 173

5. Controlled multicentre study of the influence of subcutaneous recombinant human erythropoietin on anaemia and transfusion dependency in patients with ovarian carcinoma treated with platinum-based chemotherapy

   • WW ten Bokkel Huinink
   • CAM de Swart
   • B Ehmer

   Paper 01 September 1998 Pages: 174 - 182

6. Randomised unicenter trial for comparison of three regimens inde novo adult acute nonlymphoblastic leukaemia

   • Meral Beksaç
   • Önder Arslan
   • Akin Uysal

   Paper 01 September 1998 Pages: 183 - 190

7. Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/α-interferon

   • R Katherine Alpaugh
   • Margaret von Mehren
   • Janice P Dutcher

   Paper 01 September 1998 Pages: 191 - 198

8. Inversion of chromosome 16 in accelerated phase of chronic myeloid leukaemia: report of a case and review of the literature

   • M Čolović
   • G Janković
   • PH Wiernik

   Paper 01 September 1998 Pages: 199 - 201